
Allyson Funk Ally is a former senior director of public affairs at PhRMA.
Recent Posts
The risks of counterfeit imported medicines

A recent Wall Street Journal article laid out the serious concerns posed by potent, counterfeit prescription opioids pouring into the United States from China, Mexico and Canada. The Drug Enforcement...
Read More
Medicare Monday: A guide to MedPAC’s Part B vote this week

The Medicare Payment Advisory Commission (MedPAC) is an independent congressional agency that advises Congress on issues related to the Medicare program, including payment, access to and quality of...
Read More
ICYMI: What the experts are saying about importation

Voices throughout the U.S. and Canadian health care systems have raised concerns about proposed large-scale drug importation schemes. Former government officials, pharmacy groups and experts have...
Read More
Medicare Monday: Billing code basics for biologics in Part B

We’ve explored the Centers for Medicare & Medicaid Services’ (CMS) flawed policy for reimbursing biologic and biosimilar products before. Today, we’re exploring how proposals from MedPAC would build...
Read More
How drug importation schemes could increase U.S. law enforcement burdens

In recent weeks, we’ve explored some of the dangers of importation for patients and how medicines purchased online can be fake. But what would importation schemes mean for U.S. law enforcement?
Read More
Why drug importation threatens patient safety

Counterfeit drug manufacturing and trafficking is a multi-billion dollar business. Legislative proposals to allow importation of potentially counterfeit and substandard drugs into the United States...
Read More
Fact Check Friday: The truth about drug importation and patient safety

This week on Fact Check Friday, we’re discussing the truth about proposals to allow the importation of medicines from other countries and what these proposals mean for patients. MYTH: Importation is...
Read More
What you don’t know about importation from Canada

Proposals to allow the importation of prescription medicines from Canada ignore the dangerous threat to patients of counterfeit and adulterated medicines. What actually happens when a patient orders...
Read More
Medicare Monday: Negotiation in Medicare Part D works

Earlier this year, we highlighted a new QuintilesIMS Institute research brief that, for the first time, looked at Part D costs after accounting for rebates.
Read More
Medicare Monday: Beware! Scary proposed changes to Medicare are out there

This Halloween, beware of the spooky proposals some have put forward to change how Medicare covers prescription medicines for seniors and people living with disabilities. Tricks like these are no...
Read More